Tobramycin
CLINICAL USE
Antibacterial agent
DOSE IN NORMAL RENAL FUNCTION
IM/IV: 3 mg/kg/day in 3 divided doses; maximum 5 mg/kg/day in 3–4 divided doses Urinary tract infections: 2–3 mg/kg daily as a single dose (IM)
PHARMACOKINETICS
Molecular weight                           : 467.5 %Protein binding                           : <5 %Excreted unchanged in urine     : 90 Volume of distribution (L/kg)       : 0.25 half-life – normal/ESRD (hrs)      : 2–3/5–70 DOSE IN RENAL IMPAIRMENT
GFR (mL/MIN)
20 to 50     : Give 1–2 mg/kg then dose according to serum levels 10 to 20     : Give 1 mg/kg then dose according to serum levels <10           : Give 1 mg/kg then dose according to serum levels DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES
CAPD                : Dialysed. Dose as in GFR <10 mL/min HD                     : Dialysed. Dose as in GFR <10 mL/min HDF/high flux   : Dialysed. Dose as in GFR <10 mL/min CAV/VVHD      : Dialysed. 1.5–2 mg/kg every 24 hours and monitor levels1 IMPORTANT DRUG INTERACTIONS
Potentially hazardous interactions with other drugs Botulinum toxin: neuromuscular block enhanced – risk of toxicity Ciclosporin: increased risk of nephrotoxicity Cytotoxics: increased risk of nephrotoxicity and possibly of ototoxicity with platinum compounds Diuretics: increased risk of ototoxicity with loop diuretics Muscle relaxants: enhanced effect of non-depolarising muscle relaxants and suxamethonium Parasympathomimetics: antagonism of effect of neostigmine and pyridostigmine Tacrolimus: increased risk of nephrotoxicity ADMINISTRATION
Reconstition
Add to 50–100 mL sodium chloride 0.9% or glucose 5% for IV infusion
Route
IV, IM, IP, nebulised Rate of Administration
20–60 minutes Comments
Plasma concentrations should be measured frequently; trough ≤2 mg/L, peak 60 minutes post dose ≤10 mg/L; avoid prolonged peaks above 12 mg/L OTHER INFORMATION
25–70% can be removed by haemodialysis Used via nebuliser for chronic pulmonary Pseudomonas aeruginosa infection in cystic fibrosis: 300 mg every 12 hours for 28 days, repeat after 28 days Can be used for peritonitis at doses of 6 mg/L intraperitoneally
See how to identify renal failure stages according to GFR calculation
See how to diagnose irreversible renal disease
Home